Estibaliz Pérez-Viejo. Hospital Universitario de Fuenlabrada. Fuenlabrada, Madrid. Spain

Pedro Villarejo. Hospital Universitario Fundación Jiménez Díaz. Madrid, Spain

• Harpsicle: a prospective observational study on HIPEC regimens in colorectal peritoneal metastases
  Mufaddal Kazi. Tata Memorial Hospital. Mumbai, India
• Preoperative chemotherapy cytoreductive surgery (CRS) and HIPEC in primary high-grade serous ovarian cancer with peritoneal metastases: focus on the number of cycles from PMS-SICO oncoteam
  Gianmario Edoardo Poto. University of Siena. Siena, Italy
• Optimizing preclinical models of peritoneal carcinomatosis in ovarian cancer to advance translational intraperitoneal therapies
  Mª Teresa Perelló Trias. University of the Balearic Islands (UIB). Palma, Spain
• Matrix-bound nanovesicles drive immune suppression in colorectal peritoneal metastases
  Luca Varinelli. Fondazione IRCCS Istituto nazionale dei Tumori Milano. Milan, Italy
• Is there a delay in the initiation of adjuvant chemotherapy in patients undergoing cytoreductive surgery and HIPEC?
  Cristina Pineño Flores. Hospital Universitario Son Espases. Palma, Spain
• Cytoreductive surgery plus tkis improves survival in peritoneal metastatic GISTS: a retrospective study
  Huaiming Wang. The Sixth Affiliated Hospital of Sun Yat-sen University. Guangdong Province, China